Review Article
Role of MicroRNA-1 in Human Cancer and Its Therapeutic Potentials
Table 2
Oncogenes and oncogenic pathway targets of miR-1 in cancers.
| Gene name | Genbank accession number | Chromosome location | Functions | Reference number |
| Met | NM_000245.2 | 7q31 | Proto-oncogenic receptor tyrosine kinase | [42, 44, 68] | HDAC4 | NM_006037.3 | 2q37.3 | Histone deacetylase activity; represses transcription | [14, 31, 39] | Pim-1 | NM_002648.3 | 6p21.2 | Proto-oncogene | [33] | FOXP1 | NM_001244810.1 | 3p14.1 | Regulate gene transcription; tumor suppressor | [33, 39] | TAGLN2 | NM_003564.1 | 1q21-q25 | Earliest marker of differentiated smooth muscle | [50, 56, 64] | PNP | NM_000270.3 | 14q13.1 | Purine metabolism | [50, 58] | PTMA | NM_002823.4 | 2q37.1 | Enhance cell-mediated immunity | [58] | CXCR4 | NM_001008540.1 | 2q21 | Chemokine receptor | [65] | CCND2 | NM_001759.3 | 12p13 | Regulator of cyclin-dependent kinase | [65, 71] | SRSF9 | NM_003769.2 | 12q24.31 | ā | [57] | FN1 | NM_212482.1 | 2q34 | Involved in cell adhesion, growth, and migration | [61] | ETS1 | NM_001143820.1 | 11q23.3 | Proto-oncogene | [40] | Endothelin 1 | NM_001955.4 | 6p24.1 | Involved in vascular disorders | [41] | Slug | NM_003068.4 | 8q11 | Transcriptional repressor and has antiapoptotic activity | [38] | CXCL12 | NM_199168.3 | 10q11.1 | Chemotactic for lymphocytes | [65] |
|
|